Kymera Therapeutics, Inc. (KYMR)

73.08 -4.73 (-6.08%) USD  |  NASDAQ  |  Jan 02, 13:45
More

Kymera Therapeutics Amortization of Securities (Quarterly)

Amortization of Securities (Quarterly) Chart

View Amortization of Securities (Quarterly) for KYMR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Amortization of Securities (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Amortization of Securities (Quarterly) Range, Past 5 Years

View Amortization of Securities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Amortization of Securities (Quarterly) Benchmarks

View Amortization of Securities (Quarterly) Benchmarks
Start Trial
Gilead Sciences, Inc. --
Regeneron Pharmaceuticals, Inc. --
Cytokinetics, Inc. --
TG Therapeutics, Inc. Upgrade
Protagonist Therapeutics, Inc. Upgrade